Sequenom Company Profile (NASDAQ:SQNM)

About Sequenom

Sequenom logoSequenom, Inc. is a life sciences company. The Company serves patients and physicians by providing early patient management information. The Company operates through Sequenom Laboratories segment. It conducts its business as a molecular diagnostics clinical laboratory located in San Diego, California and Raleigh-Durham, North Carolina. Its testing focus is on prenatal health that includes molecular-based laboratory developed tests (LDTs). The Company's diagnostic services are provided through its subsidiary, Sequenom Center for Molecular Medicine LLC (SCMM), doing business as Sequenom Laboratories. Sequenom Laboratories develops and validates its tests to be used as a testing service to physicians. Sequenom Laboratories is focused on developing and offering a menu of tests for prenatal continuum of care. The Sequenom Laboratories' test offerings in the prenatal market include MaterniT21 PLUS LDT, HerediT CF test, SensiGene RhD test, VisibiliT test and Test Send-out Agreements.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NASDAQ
  • Symbol: SQNM
  • CUSIP: 81733740
Key Metrics:
  • Previous Close: $0.00
  • 50 Day Moving Average: $2.16
  • 200 Day Moving Average: $1.47
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -18.38
  • P/E Growth: 0.00
  • Market Cap: $N/A
  • Beta: 1.17
  • Net Margins: -36.10%
  • Return on Assets: -35.58%
  • Debt-to-Equity Ratio: -2.35%
  • Current Ratio: 3.35%
  • Quick Ratio: 3.16%
Additional Links:
Companies Related to Sequenom:

Analyst Ratings

Consensus Ratings for Sequenom (NASDAQ:SQNM) (?)
Ratings Breakdown: 4 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $1.43 (40.38% downside)

Analysts' Ratings History for Sequenom (NASDAQ:SQNM)
DateFirmActionRatingPrice TargetDetails
7/20/2016Jefferies Group LLCReiterated RatingHold$1.50 -> $0.75View Rating Details
6/29/2016William BlairReiterated RatingMarket PerformView Rating Details
3/3/2016Piper Jaffray CompaniesReiterated RatingHold$2.10View Rating Details
3/3/2016Ladenburg Thalmann Financial ServicesUpgradeSell -> NeutralView Rating Details
11/25/2015WedbushReiterated RatingNeutral$1.50View Rating Details
5/8/2015Oppenheimer Holdings, Inc.Reiterated RatingOutperform -> BuyView Rating Details
(Data available from 2/21/2015 forward)


Earnings History for Sequenom (NASDAQ:SQNM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/4/2016Q116($0.10)($0.11)$27.85 million$27.57 millionViewN/AView Earnings Details
3/2/2016Q415($0.10)($0.10)$29.35 million$27.80 millionViewN/AView Earnings Details
11/4/2015Q315($0.09)($0.08)$31.35 million$29.90 millionViewN/AView Earnings Details
8/5/2015Q215($0.05)($0.08)$35.74 million$32.77 millionViewN/AView Earnings Details
5/6/2015Q115($0.03)$0.12$38.60 million$37.80 millionViewN/AView Earnings Details
3/4/2015Q414($0.05)$0.14$41.94 million$36.80 millionViewN/AView Earnings Details
11/4/2014Q314($0.09)($0.05)$42.80 million$37.90 millionViewN/AView Earnings Details
7/29/2014Q214($0.10)($0.07)$47.80 million$39.80 millionViewN/AView Earnings Details
5/1/2014Q114($0.14)($0.13)$46.06 million$46.30 millionViewN/AView Earnings Details
2/27/2014Q413($0.16)($0.16)$47.05 million$45.13 millionViewN/AView Earnings Details
11/7/2013Q313($0.22)($0.24)$40.56 million$43.90 millionViewN/AView Earnings Details
7/24/2013Q2 2013($0.22)($0.27)$46.25 million$24.50 millionViewN/AView Earnings Details
5/9/2013Q1 2013($0.23)($0.26)$38.29 million$38.50 millionViewN/AView Earnings Details
3/7/2013Q4 2012($0.22)($0.29)$32.02 million$33.67 millionViewN/AView Earnings Details
11/8/2012Q312($0.23)($0.26)$22.91 million$22.90 millionViewN/AView Earnings Details
7/26/2012($0.21)($0.26)ViewN/AView Earnings Details
5/3/2012($0.19)($0.22)ViewN/AView Earnings Details
3/7/2012($0.18)($0.22)ViewN/AView Earnings Details
11/3/2011($0.19)($0.19)ViewN/AView Earnings Details
8/4/2011($0.17)($0.21)ViewN/AView Earnings Details
5/5/2011($0.19)($0.13)ViewN/AView Earnings Details
3/8/2011($0.21)($0.27)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Sequenom (NASDAQ:SQNM)
Current Year EPS Consensus Estimate: $-0.30 EPS
Next Year EPS Consensus Estimate: $-0.13 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.11)($0.09)($0.10)
Q2 20161($0.10)($0.10)($0.10)
Q3 20161($0.06)($0.06)($0.06)
Q4 20162($0.09)($0.05)($0.07)
Q1 20171($0.04)($0.04)($0.04)
Q2 20171($0.04)($0.04)($0.04)
Q3 20171($0.03)($0.03)($0.03)
Q4 20171($0.03)($0.03)($0.03)
(Data provided by Zacks Investment Research)


Dividend History for Sequenom (NASDAQ:SQNM)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Sequenom (NASDAQ:SQNM)
Insider Ownership Percentage: 3.10%
Institutional Ownership Percentage: 46.03%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/7/2016Corp Of America Hol LaboratoryMajor ShareholderBuy36,649,440$2.40$87,958,656.00View SEC Filing  
6/10/2016Carolyn BeaverCFOBuy30,000$1.10$33,000.00View SEC Filing  
6/9/2016Carolyn BeaverCFOBuy10,000$1.10$11,000.00View SEC Filing  
6/9/2016Jeffrey D LintonSVPBuy5,000$1.10$5,500.00View SEC Filing  
6/8/2016Den Boom Dirk VanCEOBuy40,000$1.09$43,600.00View SEC Filing  
5/11/2016Daniel S Md GrosuCMOBuy30,000$1.11$33,300.00View SEC Filing  
5/6/2016Den Boom Dirk VanCEOBuy30,000$1.13$33,900.00View SEC Filing  
5/6/2016Jeffrey D LintonSVPBuy10,000$1.15$11,500.00View SEC Filing  
1/4/2016Camber Capital Management LlcMajor ShareholderBuy665,435$1.62$1,078,004.70View SEC Filing  
12/16/2015Camber Capital Management LlcMajor ShareholderBuy468,000$1.30$608,400.00View SEC Filing  
12/15/2015Camber Capital Management LlcMajor ShareholderBuy20,000$1.41$28,200.00View SEC Filing  
12/14/2015Camber Capital Management LlcMajor ShareholderBuy448,000$1.30$582,400.00View SEC Filing  
12/10/2015Camber Capital Management LlcMajor ShareholderBuy791,565$1.30$1,029,034.50View SEC Filing  
10/8/2015Camber Capital Management LlcMajor ShareholderBuy1,650,090$1.96$3,234,176.40View SEC Filing  
3/10/2015William J WelchCEOBuy10,000$3.65$36,500.00View SEC Filing  
3/9/2015Carolyn BeaverCFOBuy10,000$3.60$36,000.00View SEC Filing  
3/6/2015Jeffrey D LintonSVPBuy10,000$3.64$36,400.00View SEC Filing  
11/29/2012Goldman Myla LaiDirectorBuy4,000$4.59$18,360.00View SEC Filing  
11/26/2012John A FazioDirectorBuy2,000$4.45$8,900.00View SEC Filing  
8/8/2012Charles P SlacikDirectorBuy5,000$3.24$16,200.00View SEC Filing  
8/7/2012John A FazioDirectorBuy2,000$3.33$6,660.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Sequenom (NASDAQ:SQNM)
DateHeadline logoIncreasing Awareness about Chromosome Abnormalities among Women to Augment Demand for Prenatal and Newborn Genetic Testing, reports TMR (NASDAQ:SQNM) - February 18 at 8:49 AM logoCompetitive Insights: Next-Generation Sequencing for Non-Invasive Prenatal Testing Market 2016 - 2024 (NASDAQ:SQNM) - February 16 at 7:44 PM
News IconAre Analysts Optimistic About Where Sequenom, Inc. (NASDAQ:SQNM) is Heading? - Winfield Review (NASDAQ:SQNM) - February 15 at 6:11 AM
News IconSequenom Inc SQNM Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:SQNM) - February 11 at 3:35 AM
News IconNoninvasive Prenatal Testing Market Will Continue to Grow by 2021 (NASDAQ:SQNM) - February 10 at 4:55 AM
News IconNon Invasive Prenatal Testing Market Revenues and Volume by Test and Forecast 2022 (NASDAQ:SQNM) - February 9 at 5:14 AM
News IconHealthTell, Inc. Hires Gary Riordan as New Vice President of Regulatory and (NASDAQ:SQNM) - February 9 at 5:14 AM
News IconClinical Laboratory Services Market to Surpass US$ 315 Million by 2024 (NASDAQ:SQNM) - February 9 at 5:14 AM logoLabCorp seeks to acquire NC clinical trials firm PPD, per report - Triad Business Journal (NASDAQ:SQNM) - February 8 at 6:16 AM
News IconGlobal Genotyping Market Industry Trends & Forecasts to 2022 (NASDAQ:SQNM) - February 2 at 3:51 AM
News IconNext-Generation Sequencing for Non-Invasive Prenatal Testing Market - New Tech Developments and Advancements to Watch Out for 2024 (NASDAQ:SQNM) - February 2 at 3:51 AM
News IconNext-Generation Sequencing for Non-Invasive Prenatal Testing Market – New Tech Developments and Advancements to Watch Out for 2024 (NASDAQ:SQNM) - February 1 at 6:05 AM
News IconSequenom, Inc. (NASDAQ:SQNM) – Brokers Update Their Views - NewsDen (NASDAQ:SQNM) - January 28 at 6:42 AM
News IconWhat is the Street Saying About Sequenom, Inc. (NASDAQ:SQNM)? - Aiken Advocate (NASDAQ:SQNM) - January 28 at 6:42 AM logoGlobal Non-invasive Prenatal Testing (NIPT) Market to Raise at a CAGR of 15.0% over the Forecast Period by 2022 (NASDAQ:SQNM) - January 23 at 9:56 PM logoGlobal Non-Invasive Prenatal Testing Market: Increasing Preference for Late Pregnancy in Women to Boost … (NASDAQ:SQNM) - January 23 at 8:26 AM
News IconNext-Generation Sequencing for Non-Invasive Prenatal Testing Market: North America Is Expected to Grow at Highest CAGR in the Forecast Period (NASDAQ:SQNM) - January 19 at 12:19 AM
News IconNon-Invasive Prenatal Testing Industry To Reach USD 5.5 Billion By 2025: Hexa Reports (NASDAQ:SQNM) - January 14 at 7:59 PM logoNon-invasive Prenatal Testing Market to Reach US$2.4 Billion by 2022, due to Increasing Incidence of Fetal Chromosomal Disorders (NASDAQ:SQNM) - January 11 at 2:16 AM
News IconGlobal Growth Upside: Non-invasive Prenatal Testing Market to Grow at 17.50% CAGR by 2022 (NASDAQ:SQNM) - January 9 at 8:03 AM logoLLabCorp: Reimbursement Scenario a Drag Amid Other Woes (NASDAQ:SQNM) - January 9 at 8:03 AM
News IconGlobal Non-Invasive Prenatal Testing (NIPT) Market Worth US $2.38 Billion in 2022 (NASDAQ:SQNM) - January 7 at 5:03 AM
News IconNon-Invasive Prenatal Testing Market Size, Comprehensive Analysis and Outlook Forecast 2015 – 2022 (NASDAQ:SQNM) - January 6 at 5:20 AM
News IconGlobal DNA Chip Market Propelled by Growing Demand for Personalized Medicine (NASDAQ:SQNM) - January 6 at 5:20 AM
News IconWith a CAGR of 26.9% within a forecast period of 2013 to 2019, Prenatal and New-born Genetic Testing Market will be valued at US$8.37 bn (NASDAQ:SQNM) - January 5 at 6:47 AM logoNext-Generation Sequencing for Non-Invasive Prenatal Testing Market 2024: North America is expected to grow at highest CAGR in the forecast period (NASDAQ:SQNM) - January 2 at 7:45 PM
News IconFuture of Global Microarrays Market: 2015 to 2021 (NASDAQ:SQNM) - December 29 at 7:55 PM
News IconSNP Genotyping and Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 (NASDAQ:SQNM) - December 23 at 8:03 PM logoNon-Invasive Prenatal Testing Market to Grow at 15.0% CAGR by 2022 (NASDAQ:SQNM) - December 21 at 10:49 AM logoNon-Invasive Prenatal Testing (NIPT) Market Detailed Analysis and Forecast by 2022 (NASDAQ:SQNM) - December 20 at 2:49 PM
News IconReflexion Health Names Sudipto Sur, Ph.D., as New Chief Technology Officer (NASDAQ:SQNM) - December 19 at 11:24 AM logoNoninvasive Prenatal Testing Market Growth, Trends and Forecast 2014 - 2020 (NASDAQ:SQNM) - December 13 at 1:03 AM
News IconGenotyping Market size, Analysis, Trends, Report, Share, Investment Opportunities and Forecast to 2022 (NASDAQ:SQNM) - December 13 at 1:03 AM logoNoninvasive Prenatal Testing Market: Wide-Scale Applications Stimulate Growth of Global Market (NASDAQ:SQNM) - December 8 at 8:18 AM
News IconGlobal Non-invasive Prenatal Testing (NIPT) Market to Account US$ 2.38 Bn in 2022 (NASDAQ:SQNM) - November 29 at 10:22 AM
News IconSequenom, Inc. SQNM Product Pipeline Analysis, 2016 Update Prices from USD $750 (NASDAQ:SQNM) - November 25 at 10:16 AM
News IconSequenom, Inc. SQNM Medical Equipment Deals and Alliances Profile Prices from USD $250 (NASDAQ:SQNM) - November 16 at 7:53 PM
News IconExpanding on U.S. Supreme Court patent decisions may be harmful to innovation (NASDAQ:SQNM) - November 16 at 11:28 AM
News IconiPANDA – a novel approach for analyzing signaling and metabolic pathway perturbation states from RNA-Seq data (NASDAQ:SQNM) - November 16 at 11:28 AM
News IconExpanding on Supreme Court patent decisions harmful to U.S. innovation (NASDAQ:SQNM) - November 16 at 11:28 AM logoNIPTs are contributing significantly in the overall growth of laboratory-developed testing marke (NASDAQ:SQNM) - November 14 at 11:51 AM
News IconNon Invasive Prenatal Testing Nipt Market is Appraised to be Valued US$ 2.38 Bn in 2022 (NASDAQ:SQNM) - November 10 at 10:58 AM logoNext-Generation Sequencing for Non-Invasive Prenatal Testing Market: Evolving Market Trends and Dynamics (NASDAQ:SQNM) - November 9 at 10:28 AM logoBiolog expands its Board of Directors and adds key executive to lead sales & marketing (NASDAQ:SQNM) - November 8 at 11:37 AM
News IconPre-Pregnancy Genetic Testing Market Dynamics, Segments and Supply Demand 2016-2026 (NASDAQ:SQNM) - November 4 at 7:10 PM
News IconUpgrades And Downgrades For Sequenom, Inc. (NASDAQ:SQNM) - NewsDen (NASDAQ:SQNM) - October 27 at 12:34 PM
News IconStock Update on Earnings & Estimates for Sequenom, Inc. (NASDAQ:SQNM) - CSZ News (NASDAQ:SQNM) - October 22 at 11:28 AM logoLabCorp Subsidiary Sequenom, Inc. Announces Expiration of and Final Tender Results for Tender Offers for 5% Convertible Senior Notes Due 2017 and 5% Convertible Senior Exchange Notes Due 2018 (NASDAQ:SQNM) - October 18 at 12:24 PM
News IconLooking Ahead for Sequenom, Inc. (NASDAQ:SQNM); Are These Shares Ready to Go Higher? - CSZ News (NASDAQ:SQNM) - October 14 at 7:14 PM logoState clawing back $1.36M in grant incentives (NASDAQ:SQNM) - October 11 at 8:16 PM


What is Sequenom's stock symbol?

Sequenom trades on the NASDAQ under the ticker symbol "SQNM."

Where is Sequenom's stock going? Where will Sequenom's stock price be in 2017?

4 analysts have issued twelve-month price targets for Sequenom's stock. Their predictions range from $0.75 to $2.10. On average, they expect Sequenom's share price to reach $1.43 in the next twelve months.

When will Sequenom announce their earnings?

Sequenom is scheduled to release their next quarterly earnings announcement on Wednesday, November, 2nd 2016.

How do I buy Sequenom stock?

Shares of Sequenom can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Sequenom stock cost?

One share of Sequenom stock can currently be purchased for approximately $2.39.

Sequenom (NASDAQ:SQNM) Chart for Tuesday, February, 21, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for Sequenom (NASDAQ:SQNM)

Earnings History Chart

Earnings by Quarter for Sequenom (NASDAQ:SQNM)

Dividend History Chart

Dividend Payments by Quarter for Sequenom (NASDAQ:SQNM)

Last Updated on 2/21/2017 by Staff